Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
MLSS 
Milestone Scientific (MLSS)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
04/01/2025: MLSS (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
AI Based Fundamental Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit -69.77% | Avg. Invested days 23 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 04/01/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 77.11M USD | Price to earnings Ratio - | 1Y Target Price 2.12 |
Price to earnings Ratio - | 1Y Target Price 2.12 | ||
Volume (30-day avg) 92187 | Beta 1.41 | 52 Weeks Range 0.54 - 1.39 | Updated Date 03/31/2025 |
52 Weeks Range 0.54 - 1.39 | Updated Date 03/31/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.06 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2025-03-27 | When Before Market | Estimate - | Actual - |
Profitability
Profit Margin -52.01% | Operating Margin (TTM) -58.44% |
Management Effectiveness
Return on Assets (TTM) -38.46% | Return on Equity (TTM) -65.21% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 68178251 | Price to Sales(TTM) 8.34 |
Enterprise Value 68178251 | Price to Sales(TTM) 8.34 | ||
Enterprise Value to Revenue 7.68 | Enterprise Value to EBITDA -6.86 | Shares Outstanding 77892096 | Shares Floating 52250009 |
Shares Outstanding 77892096 | Shares Floating 52250009 | ||
Percent Insiders 22.9 | Percent Institutions 5.7 |
Analyst Ratings
Rating 4.5 | Target Price 2.12 | Buy 1 | Strong Buy 1 |
Buy 1 | Strong Buy 1 | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Milestone Scientific
Company Overview
History and Background
Milestone Scientific Inc. was founded in 1989. The company initially focused on developing and marketing computer-controlled drug delivery systems. Over time, it transitioned its focus to dental and medical markets, developing the Wand STA (Single Tooth Anesthesia) System and CompuFlo technology. Milestone Scientific is committed to innovation in computerized drug delivery.
Core Business Areas
- Dental: Develops, manufactures, and markets the Wand STA and related dental handpieces, needles and disposables, which delivers anesthetic in a controlled and comfortable manner.
- Medical: Develops CompuFlo epidural instrument which uses real-time pressure sensing technology for controlled fluid injection, mostly for epidurals.
Leadership and Structure
Leonard Osser serves as the Interim Chief Executive Officer and Director. The company has a board of directors overseeing the strategic direction.
Top Products and Market Share
Key Offerings
- The Wand STA System: A computer-controlled local anesthesia delivery system for dental applications. It aims to provide a more comfortable and predictable experience for patients. The competitors include traditional syringes, other computer-controlled devices like those from Aseptico or Dentsply Sirona. Market share data is fragmented, but The Wand is a significant player in the computer-controlled anesthesia market.
- CompuFlo Epidural System: A system using real-time pressure sensing technology for controlled fluid injection, intended to improve safety and accuracy during epidural procedures. Competitors include traditional loss-of-resistance syringes and techniques. The overall epidural market is large, but the CompuFlo system has a specific niche within that market for enhanced pressure feedback. Revenue numbers by product line are not publicly available.
Market Dynamics
Industry Overview
The dental and medical device industries are characterized by technological advancements, increasing demand for minimally invasive procedures, and stringent regulatory requirements. The computerized drug delivery segment is growing, driven by the desire for improved patient comfort and clinical outcomes.
Positioning
Milestone Scientific is positioned as a technology leader in computerized drug delivery, focusing on enhancing precision, safety, and patient experience in dental and medical procedures. Their competitive advantage is the proprietary CompuFlo technology.
Total Addressable Market (TAM)
The TAM for dental anesthesia and epidural markets is significant. The dental anesthesia market TAM is in the billions of dollars. The Epidural market is similarly substantial. Milestone Scientific is targeting a segment of these markets with its innovative delivery systems. Penetration into these markets is limited and presents a large growth opportunity.
Upturn SWOT Analysis
Strengths
- Proprietary CompuFlo technology
- Focus on patient comfort and safety
- Innovative product portfolio
- Established presence in dental market
- Potential for growth in medical market
Weaknesses
- Limited financial resources
- Dependence on key products
- Smaller market share compared to larger competitors
- Requires extensive training for operators
Opportunities
- Expanding into new geographic markets
- Developing new applications for CompuFlo technology
- Strategic partnerships and collaborations
- Increasing adoption of minimally invasive procedures
- Growth in geriatric dentistry
Threats
- Competition from established medical and dental device companies
- Regulatory changes
- Technological obsolescence
- Economic downturns
- Product liability claims
Competitors and Market Share
Key Competitors
- Dentsply Sirona (XRAY)
- 3M (MMM)
- Septodont (Private)
Competitive Landscape
Milestone Scientific's advantages lie in its proprietary technology and focus on patient comfort. Disadvantages include smaller size and limited financial resources compared to larger competitors. They must also compete with privately held companies such as Septodont.
Major Acquisitions
Growth Trajectory and Initiatives
Historical Growth: Historical Growth data unavailable, will use example below:
Future Projections: Future Projections unavailable, will use example below:
Recent Initiatives: Recent Initiatives include focusing on expansion in Europe and strengthening their position in medical applications.
Summary
Milestone Scientific is a company focused on computerized drug delivery, with proprietary technology that enhances patient comfort and safety. The company's strengths lie in its innovative products and potential for growth in both dental and medical applications. However, it faces challenges from larger, well-established competitors and requires careful management of its financial resources. Continued innovation and strategic partnerships will be crucial for future success.
Similar Companies
- XRAY
- MMM
- CAH
Sources and Disclaimers
Data Sources:
- Milestone Scientific Investor Relations
- SEC Filings
- Industry Reports
- Analyst Reports (where available)
Disclaimers:
The information provided is for informational purposes only and does not constitute investment advice. Market share data is based on estimates and may vary. Financial data is limited as requested by the prompt.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Milestone Scientific
Exchange NYSE MKT | Headquaters Roseland, NJ, United States | ||
IPO Launch date 1995-11-03 | Chairman of the Board & Interim CEO Mr. Neal Ira Goldman CFA | ||
Sector Healthcare | Industry Medical Instruments & Supplies | Full time employees 17 | |
Full time employees 17 | |||
Milestone Scientific Inc., a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments. Its products include CompuDent and STA Single Tooth Anesthesia System that are used for all dental procedures that require local anesthetic. In addition, the company offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances, and disposable injection handpiece for the tactile control during the injection. Further, it provides CompuFlo Epidural, a computer-controlled anesthesia system for use in various medical applications. Additionally, the company offers company offers CompuMed for use in various medical procedures performed in plastic, hair restoration, and colorectal surgery, as well as podiatry, dermatology, orthopedics, and various other disciplines. Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Roseland, New Jersey.
Upturn is now on iOS and Android!
Experience Upturn on your mobile. Install it now!
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.